- Methyl (2S)-2-{[1-(4-cyanobutyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate
- Methyl N-[1-(4-cyanobutyl)-1H-indazole-3-carbonyl]-L-valinate
Grafinger, KE; Vandeputte, MM; Cannaert, A; Ametovski, A; Sparkes, E; Cairns, E; Juchli, PO; Haschimi, B; Pulver, B; Banister, SD; Stove, CP; Auwärter, V. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays. Drug Test. Anal., 21 May 2021, 13 (7), 1412-1429. 4.3 MB. https://doi.org/10.1002/dta.3054 #20
Sparkes, E; Boyd, R; Chen, S; Markham, JW; Luo, JL; Foyzun, T; Zaman, H; Fletcher, C; Ellison, R; McGregor, IS; Santiago, MJ; Lai, F; Gerona, RR; Connor, M; Hibbs, DE; Cairns, EA; Glass, M; Ametovski, A; Banister, SD. Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs. Front. Psychiatry, 28 Sep 2022, 13 1010501. 925 kB. https://doi.org/10.3389/fpsyt.2022.1010501 #6